Brief: Immucell Corp sees FDA approval for Mast Out in 2019
11/10/2016 16:51
Oct 11 (Reuters) - Immucell Corp ICCC.O
* Immucell Corp - U.S. FDA approval for co's product Mast
Out anticipated in 2019, allowing for two, six-month reviews of
cmc technical section by FDA
Source text for Eikon: ID:nMKWVyxcXa
Further company coverage: ICCC.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year